Literature DB >> 24981749

New poly(lactic-co-glycolic acid) derivatives: Modular polymers with tailored properties.

Lea Ann Dailey1, Thomas Kissel2.   

Abstract

Poly(lactic-co-glycolic acid) (PLGA) is one of the most widely used polymers in drug delivery, despite several well-characterized shortcomings. Polymer modification is one approach to improve PLGA-based formulation properties, such as drug stability, drug release profiles, mechanism of polymer degradation and the possibility of drug targeting. A brief summary of recent reports on PLGA modifications is provided and a new class of branched polyester derivatives is introduced. In vitro and in vivo applications of the new branched polyesters as protein carriers, gene delivery vehicles, vaccine adjuvants and pulmonary drug delivery vehicles are described.:
© 2005 Elsevier Ltd . All rights reserved.

Entities:  

Year:  2005        PMID: 24981749     DOI: 10.1016/j.ddtec.2005.05.017

Source DB:  PubMed          Journal:  Drug Discov Today Technol        ISSN: 1740-6749


  5 in total

Review 1.  Advances in device and formulation technologies for pulmonary drug delivery.

Authors:  John Gar Yan Chan; Jennifer Wong; Qi Tony Zhou; Sharon Shui Yee Leung; Hak-Kim Chan
Journal:  AAPS PharmSciTech       Date:  2014-04-12       Impact factor: 3.246

Review 2.  Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review.

Authors:  You Xu; Hongmei Liu; Lei Song
Journal:  J Nanobiotechnology       Date:  2020-10-19       Impact factor: 10.435

Review 3.  PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity.

Authors:  A L Silva; P C Soema; B Slütter; F Ossendorp; W Jiskoot
Journal:  Hum Vaccin Immunother       Date:  2016-01-11       Impact factor: 3.452

Review 4.  Precision Aliphatic Polyesters via Segmer Assembly Polymerization.

Authors:  Fu-Rong Zeng; Yang Liang; Zi-Long Li
Journal:  Molecules       Date:  2018-02-18       Impact factor: 4.411

Review 5.  Application of nanotechnology in drug delivery systems for respiratory diseases (Review).

Authors:  Ming-Xin Luo; Shan Hua; Qi-Yun Shang
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.